Beroni Group (XNEC:BTG) Debt-to-Revenue : 2.42 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Beroni Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Beroni Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was A$1.41 Mil. Beroni Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was A$0.55 Mil. Beroni Group's annualized Revenue for the quarter that ended in Jun. 2023 was A$0.81 Mil. Beroni Group's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 2.42.

Beroni Group Debt-to-Revenue Historical Data

The historical data trend for Beroni Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beroni Group Debt-to-Revenue Chart

Beroni Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Revenue

Get a 7-Day Free Trial

0.10

0.65

1.84

1.43

1.74

Beroni Group Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Revenue	Get a 7-Day Free Trial									0.41	0.95	2.66	1.21	2.42

Competitive Comparison of Beroni Group's Debt-to-Revenue

For the Conglomerates subindustry, Beroni Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beroni Group's Debt-to-Revenue Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Beroni Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Beroni Group's Debt-to-Revenue falls into.

Beroni Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Beroni Group's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.988	+	0.515)	/	0.862
	=	1.74

Beroni Group's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.411	+	0.55)	/	0.81
	=	2.42

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.

Beroni Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Beroni Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Beroni Group (XNEC:BTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Beroni Group Ltd (XNEC:BTG) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

BNIGF:USA

Address

Zhong Bei High Technology Industrial Park, Level 10, Building 11, Xiqing District, Tianjin, CHN, 300380

Website

https://www.beronigroup.com

Beroni Group Ltd is an Australia based company engaged in the sale of smoking control product (NicoBloc), air purifier, healthcare products and supplements, cosmetics and stem-cell therapies. It has organized its business into four core business areas: cell therapies, developing new anticancer drugs, an e-commerce platform for pharmaceutical and healthcare products, and detection & diagnosis of infectious diseases. Its operating segment includes Nicobloc, Fogibloc air purifier, Olansi water filter, Health supplements, Cosmetic products, Viral diagnostic kits, and Technical advisory service. Geographically, it operates in China and Japan. The highest revenue is generated from the Nicobloc segment through the China region.